Pharmaceutical

Medical Care Technologies Inc. (OTC Pink:MDCE) Strengthens Foundational AI Infrastructure as Company Prepares for Next Development Milestones

MESA, ARIZONA / ACCESS Newswire / November 25, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) today confirmed that it…

2 weeks ago

Mann Eye Institute Announces Its Holiday Luxury Showcase: An Exclusive Evening of Designer Eyewear

HOUSTON, TEXAS / ACCESS Newswire / November 25, 2025 / Mann Eye Institute is kicking off the season in style…

2 weeks ago

Palisade Bio to Present at the Piper Sandler 37th Annual Healthcare Conference

Live webcast fireside chat on Thursday, December 4th at 10:30 AM ET Carlsbad, CA, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Palisade…

2 weeks ago

Xenon to Present New Azetukalner OLE Study Data in Epilepsy at AES 2025

Seven posters to be presented, including new X-TOLE OLE data supporting the ability to attain and regain extended periods of…

2 weeks ago

VSee Health’s iDoc Division Powers Ahead: Delivering on Major Contracts and Igniting Revenue Growth!

SAN JOSE, CALIFORNIA / ACCESS Newswire / November 25, 2025 / VSee Health, Inc. (NASDAQ:VSEE), a leader in innovative telemedicine…

2 weeks ago

Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Significantly Reduces PSA Levels in Human Prostate Cancer Cells

PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related…

2 weeks ago

Tiziana Life Sciences Nasal Foralumab Phase 2 Clinical Trial Accepted into Healey ALS MyMatch Program

BOSTON, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company…

2 weeks ago

UniDoc Receives Order for Health Cubes

Three units for demonstration within Verizon Innovation Labs VANCOUVER, BC / ACCESS Newswire / November 25, 2025 / UniDoc Health…

2 weeks ago

Lexicon Pharmaceuticals to Participate in Two Upcoming December Investor Conferences

THE WOODLANDS, Texas, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will…

2 weeks ago

PolyPid to Participate in ROTH Capital Partners Virtual KOL Event on December 10, 2025

Internationally recognized colorectal surgeon Steven D. Wexner, MD, FACS, FRCS, to discuss the clinical and economic burden of surgical site…

2 weeks ago